GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Name | miRBASE accession |
---|---|
hsa-miR-124-3p.2
|
|
hsa-miR-506-3p
|
- |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_13814663 | 15.95 |
ENST00000359495.2
ENST00000379170.4 |
MCUR1
|
mitochondrial calcium uniporter regulator 1 |
chr4_-_122618095 | 15.52 |
ENST00000515017.1
ENST00000501272.2 ENST00000296511.5 |
ANXA5
|
annexin A5 |
chr1_+_223900034 | 15.48 |
ENST00000295006.5
|
CAPN2
|
calpain 2, (m/II) large subunit |
chr3_-_32544900 | 14.38 |
ENST00000205636.3
|
CMTM6
|
CKLF-like MARVEL transmembrane domain containing 6 |
chr1_-_95392635 | 14.20 |
ENST00000538964.1
ENST00000394202.4 ENST00000370206.4 |
CNN3
|
calponin 3, acidic |
chr12_+_69004619 | 13.94 |
ENST00000250559.9
ENST00000393436.5 ENST00000425247.2 ENST00000489473.2 ENST00000422358.2 ENST00000541167.1 ENST00000538283.1 ENST00000341355.5 ENST00000537460.1 ENST00000450214.2 ENST00000545270.1 ENST00000538980.1 ENST00000542018.1 ENST00000543393.1 |
RAP1B
|
RAP1B, member of RAS oncogene family |
chr6_-_53213780 | 13.93 |
ENST00000304434.6
ENST00000370918.4 |
ELOVL5
|
ELOVL fatty acid elongase 5 |
chr8_+_98656336 | 13.80 |
ENST00000336273.3
|
MTDH
|
metadherin |
chr2_-_161350305 | 13.44 |
ENST00000348849.3
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1 |
chr15_-_101792137 | 13.31 |
ENST00000254190.3
|
CHSY1
|
chondroitin sulfate synthase 1 |
chr10_-_75173785 | 12.43 |
ENST00000535178.1
ENST00000372921.5 ENST00000372919.4 |
ANXA7
|
annexin A7 |
chr18_+_158513 | 12.39 |
ENST00000400266.3
ENST00000580410.1 ENST00000383589.2 ENST00000261601.7 |
USP14
|
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase) |
chr12_-_58146048 | 12.15 |
ENST00000547281.1
ENST00000546489.1 ENST00000552388.1 ENST00000540325.1 ENST00000312990.6 |
CDK4
|
cyclin-dependent kinase 4 |
chr5_-_133968529 | 11.78 |
ENST00000402673.2
|
SAR1B
|
SAR1 homolog B (S. cerevisiae) |
chr12_-_65146636 | 11.59 |
ENST00000418919.2
|
GNS
|
glucosamine (N-acetyl)-6-sulfatase |
chr2_-_152684977 | 11.48 |
ENST00000428992.2
ENST00000295087.8 |
ARL5A
|
ADP-ribosylation factor-like 5A |
chr1_+_113161778 | 11.46 |
ENST00000263168.3
|
CAPZA1
|
capping protein (actin filament) muscle Z-line, alpha 1 |
chr8_+_59465728 | 11.37 |
ENST00000260130.4
ENST00000422546.2 ENST00000447182.2 ENST00000413219.2 ENST00000424270.2 ENST00000523483.1 ENST00000520168.1 |
SDCBP
|
syndecan binding protein (syntenin) |
chr2_+_178257372 | 11.35 |
ENST00000264167.4
ENST00000409888.1 |
AGPS
|
alkylglycerone phosphate synthase |
chr16_+_67063036 | 11.22 |
ENST00000290858.6
ENST00000564034.1 |
CBFB
|
core-binding factor, beta subunit |
chr3_-_120170052 | 11.16 |
ENST00000295633.3
|
FSTL1
|
follistatin-like 1 |
chr5_+_141488070 | 11.02 |
ENST00000253814.4
|
NDFIP1
|
Nedd4 family interacting protein 1 |
chr1_+_182992545 | 10.60 |
ENST00000258341.4
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2) |
chr1_+_116184566 | 10.50 |
ENST00000355485.2
ENST00000369510.4 |
VANGL1
|
VANGL planar cell polarity protein 1 |
chrX_+_135067576 | 10.38 |
ENST00000370701.1
ENST00000370698.3 ENST00000370695.4 |
SLC9A6
|
solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6 |
chr5_-_137878887 | 10.32 |
ENST00000507939.1
ENST00000572514.1 ENST00000499810.2 ENST00000360541.5 |
ETF1
|
eukaryotic translation termination factor 1 |
chr7_+_77166592 | 10.25 |
ENST00000248594.6
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12 |
chr5_+_65440032 | 10.18 |
ENST00000334121.6
|
SREK1
|
splicing regulatory glutamine/lysine-rich protein 1 |
chr7_+_39663061 | 10.12 |
ENST00000005257.2
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related) |
chrX_-_109561294 | 9.99 |
ENST00000372059.2
ENST00000262844.5 |
AMMECR1
|
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
chr5_+_32585605 | 9.93 |
ENST00000265073.4
ENST00000515355.1 ENST00000502897.1 ENST00000510442.1 |
SUB1
|
SUB1 homolog (S. cerevisiae) |
chr1_-_70671216 | 9.92 |
ENST00000370952.3
|
LRRC40
|
leucine rich repeat containing 40 |
chr1_-_6295975 | 9.89 |
ENST00000343813.5
ENST00000362035.3 |
ICMT
|
isoprenylcysteine carboxyl methyltransferase |
chr15_+_45315302 | 9.89 |
ENST00000267814.9
|
SORD
|
sorbitol dehydrogenase |
chr18_-_9614515 | 9.79 |
ENST00000400556.3
ENST00000400555.3 |
PPP4R1
|
protein phosphatase 4, regulatory subunit 1 |
chr2_-_153574480 | 9.72 |
ENST00000410080.1
|
PRPF40A
|
PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae) |
chr3_+_69812877 | 9.65 |
ENST00000457080.1
ENST00000328528.6 |
MITF
|
microphthalmia-associated transcription factor |
chr16_-_84651673 | 9.58 |
ENST00000262428.4
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
chr1_+_160175117 | 9.35 |
ENST00000360472.4
|
PEA15
|
phosphoprotein enriched in astrocytes 15 |
chr6_-_52441713 | 9.26 |
ENST00000182527.3
|
TRAM2
|
translocation associated membrane protein 2 |
chr4_-_1714037 | 9.25 |
ENST00000488267.1
ENST00000429429.2 ENST00000480936.1 |
SLBP
|
stem-loop binding protein |
chr1_-_222885770 | 9.25 |
ENST00000355727.2
ENST00000340020.6 |
AIDA
|
axin interactor, dorsalization associated |
chr2_+_46769798 | 9.23 |
ENST00000238738.4
|
RHOQ
|
ras homolog family member Q |
chr6_-_109703663 | 9.15 |
ENST00000368961.5
|
CD164
|
CD164 molecule, sialomucin |
chr10_-_74856608 | 9.12 |
ENST00000307116.2
ENST00000373008.2 ENST00000412021.2 ENST00000394890.2 ENST00000263556.3 ENST00000440381.1 |
P4HA1
|
prolyl 4-hydroxylase, alpha polypeptide I |
chr1_+_7831323 | 9.10 |
ENST00000054666.6
|
VAMP3
|
vesicle-associated membrane protein 3 |
chr3_-_167452614 | 9.03 |
ENST00000392750.2
ENST00000464360.1 ENST00000492139.1 ENST00000471885.1 ENST00000470131.1 |
PDCD10
|
programmed cell death 10 |
chr5_-_98262240 | 9.00 |
ENST00000284049.3
|
CHD1
|
chromodomain helicase DNA binding protein 1 |
chr9_+_470288 | 8.98 |
ENST00000382303.1
|
KANK1
|
KN motif and ankyrin repeat domains 1 |
chr2_-_174830430 | 8.98 |
ENST00000310015.6
ENST00000455789.2 |
SP3
|
Sp3 transcription factor |
chr1_+_110527308 | 8.89 |
ENST00000369799.5
|
AHCYL1
|
adenosylhomocysteinase-like 1 |
chr7_-_6523755 | 8.78 |
ENST00000436575.1
ENST00000258739.4 |
DAGLB
KDELR2
|
diacylglycerol lipase, beta KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
chr5_-_131563501 | 8.73 |
ENST00000401867.1
ENST00000379086.1 ENST00000418055.1 ENST00000453286.1 ENST00000166534.4 |
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II |
chr1_+_51701924 | 8.66 |
ENST00000242719.3
|
RNF11
|
ring finger protein 11 |
chr14_-_64010046 | 8.64 |
ENST00000337537.3
|
PPP2R5E
|
protein phosphatase 2, regulatory subunit B', epsilon isoform |
chr8_+_42249418 | 8.63 |
ENST00000521158.1
ENST00000022615.4 |
VDAC3
|
voltage-dependent anion channel 3 |
chr1_-_150947343 | 8.53 |
ENST00000271688.6
ENST00000368954.5 |
CERS2
|
ceramide synthase 2 |
chr3_+_105085734 | 8.53 |
ENST00000306107.5
|
ALCAM
|
activated leukocyte cell adhesion molecule |
chr7_-_105925558 | 8.51 |
ENST00000222553.3
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
chr5_+_154092396 | 8.47 |
ENST00000336314.4
|
LARP1
|
La ribonucleoprotein domain family, member 1 |
chr10_+_105726862 | 8.45 |
ENST00000335753.4
ENST00000369755.3 |
SLK
|
STE20-like kinase |
chr1_-_55352834 | 8.36 |
ENST00000371269.3
|
DHCR24
|
24-dehydrocholesterol reductase |
chrX_-_10645773 | 8.35 |
ENST00000453318.2
|
MID1
|
midline 1 (Opitz/BBB syndrome) |
chr11_+_111807863 | 8.29 |
ENST00000440460.2
|
DIXDC1
|
DIX domain containing 1 |
chr6_+_160390102 | 8.19 |
ENST00000356956.1
|
IGF2R
|
insulin-like growth factor 2 receptor |
chr22_-_36784035 | 8.16 |
ENST00000216181.5
|
MYH9
|
myosin, heavy chain 9, non-muscle |
chr20_+_16710606 | 8.11 |
ENST00000377943.5
ENST00000246071.6 |
SNRPB2
|
small nuclear ribonucleoprotein polypeptide B |
chr15_-_52861394 | 7.96 |
ENST00000563277.1
ENST00000566423.1 |
ARPP19
|
cAMP-regulated phosphoprotein, 19kDa |
chr5_+_151151471 | 7.95 |
ENST00000394123.3
ENST00000543466.1 |
G3BP1
|
GTPase activating protein (SH3 domain) binding protein 1 |
chr11_+_60681346 | 7.84 |
ENST00000227525.3
|
TMEM109
|
transmembrane protein 109 |
chr1_+_32645269 | 7.74 |
ENST00000373610.3
|
TXLNA
|
taxilin alpha |
chr3_-_72496035 | 7.66 |
ENST00000477973.2
|
RYBP
|
RING1 and YY1 binding protein |
chrX_+_123095155 | 7.54 |
ENST00000371160.1
ENST00000435103.1 |
STAG2
|
stromal antigen 2 |
chr16_-_66785699 | 7.54 |
ENST00000258198.2
|
DYNC1LI2
|
dynein, cytoplasmic 1, light intermediate chain 2 |
chr5_+_172410757 | 7.53 |
ENST00000519374.1
ENST00000519911.1 ENST00000265093.4 ENST00000517669.1 |
ATP6V0E1
|
ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 |
chr1_-_19638566 | 7.44 |
ENST00000330072.5
ENST00000235835.3 |
AKR7A2
|
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
chr15_-_73925651 | 7.26 |
ENST00000545878.1
ENST00000287226.8 ENST00000345330.4 |
NPTN
|
neuroplastin |
chr12_+_1800179 | 7.20 |
ENST00000357103.4
|
ADIPOR2
|
adiponectin receptor 2 |
chr17_+_40761660 | 7.03 |
ENST00000251413.3
ENST00000591509.1 |
TUBG1
|
tubulin, gamma 1 |
chr2_-_131267239 | 6.94 |
ENST00000451531.2
|
POTEI
|
POTE ankyrin domain family, member I |
chr15_-_55562582 | 6.87 |
ENST00000396307.2
|
RAB27A
|
RAB27A, member RAS oncogene family |
chr1_+_193091080 | 6.83 |
ENST00000367435.3
|
CDC73
|
cell division cycle 73 |
chr2_-_3523507 | 6.76 |
ENST00000327435.6
|
ADI1
|
acireductone dioxygenase 1 |
chrX_-_77150985 | 6.63 |
ENST00000358075.6
|
MAGT1
|
magnesium transporter 1 |
chr1_-_101360331 | 6.62 |
ENST00000416479.1
ENST00000370113.3 |
EXTL2
|
exostosin-like glycosyltransferase 2 |
chr1_+_178995021 | 6.61 |
ENST00000263733.4
|
FAM20B
|
family with sequence similarity 20, member B |
chr16_+_71929397 | 6.55 |
ENST00000537613.1
ENST00000424485.2 ENST00000606369.1 ENST00000329908.8 ENST00000538850.1 ENST00000541918.1 ENST00000534994.1 ENST00000378798.5 ENST00000539186.1 |
IST1
|
increased sodium tolerance 1 homolog (yeast) |
chr15_+_90931450 | 6.52 |
ENST00000268182.5
ENST00000560738.1 ENST00000560418.1 |
IQGAP1
|
IQ motif containing GTPase activating protein 1 |
chr22_+_35653445 | 6.45 |
ENST00000420166.1
ENST00000444518.2 ENST00000455359.1 ENST00000216106.5 |
HMGXB4
|
HMG box domain containing 4 |
chr7_+_17338239 | 6.43 |
ENST00000242057.4
|
AHR
|
aryl hydrocarbon receptor |
chr2_-_26101374 | 6.35 |
ENST00000435504.4
|
ASXL2
|
additional sex combs like 2 (Drosophila) |
chr20_+_31407692 | 6.34 |
ENST00000375571.5
|
MAPRE1
|
microtubule-associated protein, RP/EB family, member 1 |
chr3_-_125313934 | 6.30 |
ENST00000296220.5
|
OSBPL11
|
oxysterol binding protein-like 11 |
chr2_+_65216462 | 6.12 |
ENST00000234256.3
|
SLC1A4
|
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
chr15_+_41523335 | 6.11 |
ENST00000334660.5
|
CHP1
|
calcineurin-like EF-hand protein 1 |
chr16_-_11680791 | 6.03 |
ENST00000571976.1
ENST00000413364.2 |
LITAF
|
lipopolysaccharide-induced TNF factor |
chr17_+_57784826 | 6.02 |
ENST00000262291.4
|
VMP1
|
vacuole membrane protein 1 |
chr19_-_4867665 | 6.01 |
ENST00000592528.1
ENST00000589494.1 ENST00000585479.1 ENST00000221957.4 |
PLIN3
|
perilipin 3 |
chr7_+_66386204 | 5.97 |
ENST00000341567.4
ENST00000607045.1 |
TMEM248
|
transmembrane protein 248 |
chr7_+_24612935 | 5.93 |
ENST00000222644.5
|
MPP6
|
membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) |
chr1_+_93913713 | 5.90 |
ENST00000604705.1
ENST00000370253.2 |
FNBP1L
|
formin binding protein 1-like |
chr10_+_76970509 | 5.77 |
ENST00000332211.6
ENST00000535553.1 ENST00000313132.4 |
VDAC2
|
voltage-dependent anion channel 2 |
chr22_-_50746027 | 5.67 |
ENST00000425954.1
ENST00000449103.1 |
PLXNB2
|
plexin B2 |
chrX_-_132549506 | 5.64 |
ENST00000370828.3
|
GPC4
|
glypican 4 |
chr5_-_142783175 | 5.62 |
ENST00000231509.3
ENST00000394464.2 |
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
chr20_-_61847586 | 5.62 |
ENST00000370339.3
|
YTHDF1
|
YTH domain family, member 1 |
chr3_+_141106643 | 5.55 |
ENST00000514251.1
|
ZBTB38
|
zinc finger and BTB domain containing 38 |
chr8_-_102217796 | 5.51 |
ENST00000519744.1
ENST00000311212.4 ENST00000521272.1 ENST00000519882.1 |
ZNF706
|
zinc finger protein 706 |
chr11_-_115375107 | 5.50 |
ENST00000545380.1
ENST00000452722.3 ENST00000537058.1 ENST00000536727.1 ENST00000542447.2 ENST00000331581.6 |
CADM1
|
cell adhesion molecule 1 |
chr8_+_48920960 | 5.50 |
ENST00000523111.2
ENST00000523432.1 ENST00000521346.1 ENST00000517630.1 |
UBE2V2
|
ubiquitin-conjugating enzyme E2 variant 2 |
chr8_+_98881268 | 5.47 |
ENST00000254898.5
ENST00000524308.1 ENST00000522025.2 |
MATN2
|
matrilin 2 |
chr1_+_15736359 | 5.46 |
ENST00000375980.4
|
EFHD2
|
EF-hand domain family, member D2 |
chr3_-_12705600 | 5.45 |
ENST00000542177.1
ENST00000442415.2 ENST00000251849.4 |
RAF1
|
v-raf-1 murine leukemia viral oncogene homolog 1 |
chr12_+_96588143 | 5.41 |
ENST00000228741.3
ENST00000547249.1 |
ELK3
|
ELK3, ETS-domain protein (SRF accessory protein 2) |
chr20_+_62496596 | 5.35 |
ENST00000369927.4
ENST00000346249.4 ENST00000348257.5 ENST00000352482.4 ENST00000351424.4 ENST00000217121.5 ENST00000358548.4 |
TPD52L2
|
tumor protein D52-like 2 |
chr17_-_8534067 | 5.31 |
ENST00000360416.3
ENST00000269243.4 |
MYH10
|
myosin, heavy chain 10, non-muscle |
chr15_+_66161871 | 5.31 |
ENST00000569896.1
|
RAB11A
|
RAB11A, member RAS oncogene family |
chr22_-_38669030 | 5.29 |
ENST00000361906.3
|
TMEM184B
|
transmembrane protein 184B |
chr5_-_39425068 | 5.23 |
ENST00000515700.1
ENST00000339788.6 |
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
chr3_+_87276407 | 5.13 |
ENST00000471660.1
ENST00000263780.4 ENST00000494980.1 |
CHMP2B
|
charged multivesicular body protein 2B |
chr6_+_146864829 | 5.10 |
ENST00000367495.3
|
RAB32
|
RAB32, member RAS oncogene family |
chr9_+_117350009 | 5.07 |
ENST00000374050.3
|
ATP6V1G1
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 |
chr12_+_111843749 | 5.05 |
ENST00000341259.2
|
SH2B3
|
SH2B adaptor protein 3 |
chr4_+_41362796 | 5.02 |
ENST00000508501.1
ENST00000512946.1 ENST00000313860.7 ENST00000512632.1 ENST00000512820.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr5_-_94890648 | 4.97 |
ENST00000513823.1
ENST00000514952.1 ENST00000358746.2 |
TTC37
|
tetratricopeptide repeat domain 37 |
chr14_+_23340822 | 4.87 |
ENST00000359591.4
|
LRP10
|
low density lipoprotein receptor-related protein 10 |
chr17_+_57642886 | 4.83 |
ENST00000251241.4
ENST00000451169.2 ENST00000425628.3 ENST00000584385.1 ENST00000580030.1 |
DHX40
|
DEAH (Asp-Glu-Ala-His) box polypeptide 40 |
chr20_+_306221 | 4.82 |
ENST00000342665.2
|
SOX12
|
SRY (sex determining region Y)-box 12 |
chr12_-_118498958 | 4.82 |
ENST00000315436.3
|
WSB2
|
WD repeat and SOCS box containing 2 |
chr8_-_17104356 | 4.81 |
ENST00000361272.4
ENST00000523917.1 |
CNOT7
|
CCR4-NOT transcription complex, subunit 7 |
chr10_-_88281494 | 4.77 |
ENST00000298767.5
|
WAPAL
|
wings apart-like homolog (Drosophila) |
chr17_-_41174424 | 4.73 |
ENST00000355653.3
|
VAT1
|
vesicle amine transport 1 |
chr14_+_50359773 | 4.65 |
ENST00000298316.5
|
ARF6
|
ADP-ribosylation factor 6 |
chr3_+_187930719 | 4.65 |
ENST00000312675.4
|
LPP
|
LIM domain containing preferred translocation partner in lipoma |
chr1_+_179050512 | 4.62 |
ENST00000367627.3
|
TOR3A
|
torsin family 3, member A |
chr12_+_70636765 | 4.54 |
ENST00000552231.1
ENST00000229195.3 ENST00000547780.1 ENST00000418359.3 |
CNOT2
|
CCR4-NOT transcription complex, subunit 2 |
chr7_-_131241361 | 4.52 |
ENST00000378555.3
ENST00000322985.9 ENST00000541194.1 ENST00000537928.1 |
PODXL
|
podocalyxin-like |
chr5_-_43483929 | 4.50 |
ENST00000500337.2
ENST00000506860.1 ENST00000510130.1 ENST00000397080.3 ENST00000512085.1 |
C5orf28
|
chromosome 5 open reading frame 28 |
chr1_+_39456895 | 4.46 |
ENST00000432648.3
ENST00000446189.2 ENST00000372984.4 |
AKIRIN1
|
akirin 1 |
chr12_+_123237321 | 4.46 |
ENST00000280557.6
ENST00000455982.2 |
DENR
|
density-regulated protein |
chr3_+_169684553 | 4.45 |
ENST00000337002.4
ENST00000480708.1 |
SEC62
|
SEC62 homolog (S. cerevisiae) |
chr17_-_7297833 | 4.43 |
ENST00000571802.1
ENST00000576201.1 ENST00000573213.1 ENST00000324822.11 |
TMEM256-PLSCR3
|
TMEM256-PLSCR3 readthrough (NMD candidate) |
chr14_+_70078303 | 4.39 |
ENST00000342745.4
|
KIAA0247
|
KIAA0247 |
chr5_+_34656331 | 4.39 |
ENST00000265109.3
|
RAI14
|
retinoic acid induced 14 |
chr4_-_17513702 | 4.38 |
ENST00000428702.2
ENST00000508623.1 ENST00000513615.1 |
QDPR
|
quinoid dihydropteridine reductase |
chr14_-_35099315 | 4.36 |
ENST00000396526.3
ENST00000396534.3 ENST00000355110.5 ENST00000557265.1 |
SNX6
|
sorting nexin 6 |
chr10_+_89419370 | 4.35 |
ENST00000361175.4
ENST00000456849.1 |
PAPSS2
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
chrX_-_131352152 | 4.30 |
ENST00000342983.2
|
RAP2C
|
RAP2C, member of RAS oncogene family |
chr19_-_42759300 | 4.28 |
ENST00000222329.4
|
ERF
|
Ets2 repressor factor |
chr12_+_95867727 | 4.27 |
ENST00000323666.5
ENST00000546753.1 |
METAP2
|
methionyl aminopeptidase 2 |
chr17_-_40540377 | 4.25 |
ENST00000404395.3
ENST00000389272.3 ENST00000585517.1 ENST00000588065.1 |
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor) |
chr15_+_91073111 | 4.25 |
ENST00000420329.2
|
CRTC3
|
CREB regulated transcription coactivator 3 |
chr1_-_39339777 | 4.23 |
ENST00000397572.2
|
MYCBP
|
MYC binding protein |
chr7_-_35077653 | 4.20 |
ENST00000310974.4
|
DPY19L1
|
dpy-19-like 1 (C. elegans) |
chr6_+_148663729 | 4.20 |
ENST00000367467.3
|
SASH1
|
SAM and SH3 domain containing 1 |
chr16_-_85045131 | 4.20 |
ENST00000313732.4
|
ZDHHC7
|
zinc finger, DHHC-type containing 7 |
chr3_-_69435224 | 4.17 |
ENST00000398540.3
|
FRMD4B
|
FERM domain containing 4B |
chr14_-_23504087 | 4.15 |
ENST00000493471.2
ENST00000460922.2 |
PSMB5
|
proteasome (prosome, macropain) subunit, beta type, 5 |
chr5_+_271752 | 4.15 |
ENST00000505221.1
ENST00000509581.1 ENST00000507528.1 |
PDCD6
|
programmed cell death 6 |
chr12_-_75905374 | 4.11 |
ENST00000438169.2
ENST00000229214.4 |
KRR1
|
KRR1, small subunit (SSU) processome component, homolog (yeast) |
chr9_-_123605177 | 4.08 |
ENST00000373904.5
ENST00000210313.3 |
PSMD5
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 5 |
chr1_+_193028552 | 4.07 |
ENST00000400968.2
ENST00000432079.1 |
TROVE2
|
TROVE domain family, member 2 |
chr6_+_143929307 | 4.06 |
ENST00000427704.2
ENST00000305766.6 |
PHACTR2
|
phosphatase and actin regulator 2 |
chr14_+_60715928 | 4.01 |
ENST00000395076.4
|
PPM1A
|
protein phosphatase, Mg2+/Mn2+ dependent, 1A |
chr3_+_37903432 | 3.98 |
ENST00000443503.2
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
chr5_+_70883117 | 3.94 |
ENST00000340941.6
|
MCCC2
|
methylcrotonoyl-CoA carboxylase 2 (beta) |
chr11_+_125462690 | 3.92 |
ENST00000392708.4
ENST00000529196.1 ENST00000531491.1 |
STT3A
|
STT3A, subunit of the oligosaccharyltransferase complex (catalytic) |
chr3_-_67705006 | 3.87 |
ENST00000492795.1
ENST00000493112.1 ENST00000307227.5 |
SUCLG2
|
succinate-CoA ligase, GDP-forming, beta subunit |
chr1_-_244013384 | 3.85 |
ENST00000366539.1
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3 |
chr2_-_242212227 | 3.84 |
ENST00000427007.1
ENST00000458564.1 ENST00000452065.1 ENST00000427183.2 ENST00000426343.1 ENST00000422080.1 ENST00000449504.1 ENST00000449864.1 ENST00000391975.1 |
HDLBP
|
high density lipoprotein binding protein |
chr5_-_136834982 | 3.79 |
ENST00000510689.1
ENST00000394945.1 |
SPOCK1
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
chr12_+_121148228 | 3.78 |
ENST00000344651.4
|
UNC119B
|
unc-119 homolog B (C. elegans) |
chr3_-_11762202 | 3.70 |
ENST00000445411.1
ENST00000404339.1 ENST00000273038.3 |
VGLL4
|
vestigial like 4 (Drosophila) |
chr10_+_88516396 | 3.69 |
ENST00000372037.3
|
BMPR1A
|
bone morphogenetic protein receptor, type IA |
chr9_-_14314066 | 3.69 |
ENST00000397575.3
|
NFIB
|
nuclear factor I/B |
chr6_+_88182643 | 3.65 |
ENST00000369556.3
ENST00000544441.1 ENST00000369552.4 ENST00000369557.5 |
SLC35A1
|
solute carrier family 35 (CMP-sialic acid transporter), member A1 |
chr6_+_35995488 | 3.64 |
ENST00000229795.3
|
MAPK14
|
mitogen-activated protein kinase 14 |
chr22_-_32808194 | 3.64 |
ENST00000451746.2
ENST00000216038.5 |
RTCB
|
RNA 2',3'-cyclic phosphate and 5'-OH ligase |
chr7_-_25019760 | 3.63 |
ENST00000352860.1
ENST00000353930.1 ENST00000431825.2 ENST00000313367.2 |
OSBPL3
|
oxysterol binding protein-like 3 |
chr3_-_98312548 | 3.61 |
ENST00000264193.2
|
CPOX
|
coproporphyrinogen oxidase |
chr3_+_183415558 | 3.60 |
ENST00000305135.5
|
YEATS2
|
YEATS domain containing 2 |
chr19_+_2785458 | 3.54 |
ENST00000307741.6
ENST00000585338.1 |
THOP1
|
thimet oligopeptidase 1 |
chr2_+_7057523 | 3.50 |
ENST00000320892.6
|
RNF144A
|
ring finger protein 144A |
chr17_+_38375574 | 3.47 |
ENST00000323571.4
ENST00000585043.1 ENST00000394103.3 ENST00000536600.1 |
WIPF2
|
WAS/WASL interacting protein family, member 2 |
chr9_-_34637718 | 3.45 |
ENST00000378892.1
ENST00000277010.4 |
SIGMAR1
|
sigma non-opioid intracellular receptor 1 |
chr8_+_56014949 | 3.44 |
ENST00000327381.6
|
XKR4
|
XK, Kell blood group complex subunit-related family, member 4 |
chr7_-_87849340 | 3.40 |
ENST00000419179.1
ENST00000265729.2 |
SRI
|
sorcin |
chr15_-_52821247 | 3.31 |
ENST00000399231.3
ENST00000399233.2 |
MYO5A
|
myosin VA (heavy chain 12, myoxin) |
chr18_-_18691739 | 3.27 |
ENST00000399799.2
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1 |
chr4_+_129730779 | 3.26 |
ENST00000226319.6
|
PHF17
|
jade family PHD finger 1 |
chr3_-_52739762 | 3.25 |
ENST00000487642.1
ENST00000464705.1 ENST00000491606.1 ENST00000489119.1 ENST00000478968.2 |
GLT8D1
|
glycosyltransferase 8 domain containing 1 |
chr16_-_20911641 | 3.24 |
ENST00000564349.1
ENST00000324344.4 |
ERI2
DCUN1D3
|
ERI1 exoribonuclease family member 2 DCN1, defective in cullin neddylation 1, domain containing 3 |
chr18_-_19284724 | 3.22 |
ENST00000580981.1
ENST00000289119.2 |
ABHD3
|
abhydrolase domain containing 3 |
chr4_+_77870856 | 3.20 |
ENST00000264893.6
ENST00000502584.1 ENST00000510641.1 |
SEPT11
|
septin 11 |
chr2_+_122513109 | 3.20 |
ENST00000389682.3
ENST00000536142.1 |
TSN
|
translin |
chr3_-_47823298 | 3.18 |
ENST00000254480.5
|
SMARCC1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
chr14_+_103058948 | 3.17 |
ENST00000262241.6
|
RCOR1
|
REST corepressor 1 |
chr12_-_58240470 | 3.17 |
ENST00000548823.1
ENST00000398073.2 |
CTDSP2
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
chr7_-_137686791 | 3.16 |
ENST00000452463.1
ENST00000330387.6 ENST00000456390.1 |
CREB3L2
|
cAMP responsive element binding protein 3-like 2 |
chr12_-_123011536 | 3.11 |
ENST00000331738.7
ENST00000354654.2 |
RSRC2
|
arginine/serine-rich coiled-coil 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
3.8 | 11.3 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
3.7 | 11.0 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
3.3 | 9.9 | GO:0006059 | hexitol metabolic process(GO:0006059) |
3.0 | 9.0 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
2.8 | 8.5 | GO:1901355 | response to rapamycin(GO:1901355) |
2.7 | 16.4 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
2.7 | 8.2 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
2.7 | 15.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
2.4 | 12.1 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
2.4 | 7.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
2.3 | 11.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
2.1 | 6.3 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
1.9 | 13.5 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
1.9 | 9.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.8 | 9.0 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
1.8 | 5.3 | GO:0021678 | fourth ventricle development(GO:0021592) third ventricle development(GO:0021678) |
1.8 | 5.3 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
1.7 | 8.5 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
1.7 | 8.4 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
1.7 | 6.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.6 | 6.2 | GO:0015808 | L-alanine transport(GO:0015808) |
1.5 | 9.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.5 | 4.5 | GO:0002188 | translation reinitiation(GO:0002188) |
1.4 | 8.6 | GO:0015853 | adenine transport(GO:0015853) |
1.4 | 4.2 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.4 | 5.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.3 | 6.7 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
1.3 | 5.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.3 | 9.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
1.3 | 5.2 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
1.3 | 10.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.3 | 8.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.2 | 4.9 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
1.2 | 3.7 | GO:0048382 | mesendoderm development(GO:0048382) |
1.2 | 17.9 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
1.2 | 22.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.1 | 6.9 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
1.1 | 4.5 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.1 | 4.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
1.0 | 4.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.0 | 3.0 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
1.0 | 4.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.0 | 8.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.9 | 4.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.9 | 10.2 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.9 | 6.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.9 | 11.7 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.8 | 10.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.8 | 4.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.8 | 1.7 | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.8 | 4.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.8 | 7.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.8 | 4.8 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.8 | 2.3 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.8 | 15.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.8 | 3.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.8 | 10.7 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.8 | 6.1 | GO:0070885 | positive regulation of sodium:proton antiporter activity(GO:0032417) negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.8 | 3.1 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.8 | 3.0 | GO:0061643 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
0.8 | 2.3 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.8 | 6.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.8 | 8.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.8 | 6.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.7 | 7.4 | GO:0044598 | polyketide metabolic process(GO:0030638) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.7 | 10.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.7 | 4.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.7 | 5.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.7 | 3.6 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.7 | 12.3 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.7 | 9.2 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.7 | 2.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.7 | 7.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.7 | 4.0 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.7 | 3.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
0.6 | 4.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.6 | 6.3 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.6 | 14.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.6 | 7.4 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) |
0.6 | 11.6 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.6 | 7.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.6 | 1.7 | GO:0042823 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
0.6 | 6.8 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.6 | 1.7 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.6 | 5.5 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.5 | 3.7 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.5 | 7.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.5 | 9.2 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.5 | 2.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.5 | 1.5 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.5 | 4.5 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.5 | 14.0 | GO:0051923 | sulfation(GO:0051923) |
0.5 | 3.4 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.5 | 2.4 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.5 | 4.8 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.5 | 1.4 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.5 | 2.8 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.5 | 2.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.5 | 1.4 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.4 | 2.2 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.4 | 21.8 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.4 | 8.8 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.4 | 3.9 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.4 | 1.7 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
0.4 | 7.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.4 | 1.7 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.4 | 11.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.4 | 5.4 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.4 | 10.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.4 | 12.4 | GO:0009651 | response to salt stress(GO:0009651) |
0.4 | 2.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.4 | 11.6 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.4 | 2.2 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.4 | 3.7 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.4 | 2.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.4 | 1.5 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.4 | 3.6 | GO:0051597 | response to methylmercury(GO:0051597) |
0.4 | 4.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.4 | 1.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.3 | 4.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 0.7 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.3 | 0.7 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.3 | 10.8 | GO:0090383 | phagosome acidification(GO:0090383) |
0.3 | 6.4 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.3 | 3.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 2.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.3 | 0.9 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.3 | 2.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 0.6 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
0.3 | 3.8 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.3 | 1.3 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.3 | 2.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 5.6 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.3 | 1.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 1.3 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.3 | 0.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 9.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.3 | 1.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 3.4 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.2 | 3.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 7.5 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.2 | 1.9 | GO:0097105 | negative regulation of excitatory postsynaptic potential(GO:0090394) presynaptic membrane assembly(GO:0097105) |
0.2 | 1.9 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.3 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.2 | 1.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 5.5 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 2.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 3.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 2.5 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 1.4 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 1.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 13.5 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.2 | 10.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 1.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 5.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.2 | 1.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 1.7 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.2 | 0.6 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 0.6 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 3.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 1.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 3.2 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.2 | 6.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 0.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 3.9 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.2 | 1.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 8.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.2 | 0.9 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.2 | 0.6 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.2 | 4.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 3.8 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 10.0 | GO:0001895 | retina homeostasis(GO:0001895) |
0.2 | 0.9 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.1 | 1.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.9 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.1 | 7.5 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
0.1 | 1.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) paranodal junction assembly(GO:0030913) |
0.1 | 15.9 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 7.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 2.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 4.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 1.5 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 2.7 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 8.0 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 8.4 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 1.0 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 2.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.2 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) |
0.1 | 2.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.8 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 2.8 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.1 | 0.6 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.1 | 4.1 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 2.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.2 | GO:1901656 | glycoside transport(GO:1901656) |
0.1 | 7.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.2 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.1 | 6.4 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.1 | 0.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.3 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.1 | 0.4 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 2.2 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.1 | 4.6 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 1.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 2.8 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 2.0 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.8 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.8 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 4.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 3.9 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 2.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 4.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 4.4 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.1 | 2.5 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.1 | 0.9 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 2.0 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 4.2 | GO:0042116 | macrophage activation(GO:0042116) |
0.1 | 6.0 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 1.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 3.1 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.2 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.1 | 2.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 1.9 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 1.5 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.1 | 2.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 2.2 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.1 | 3.8 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.1 | 2.4 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.1 | 2.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 3.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 3.9 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.5 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 1.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 2.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 1.5 | GO:0090307 | mitotic spindle assembly(GO:0090307) |
0.0 | 3.2 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 3.0 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.0 | 7.0 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 2.1 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.0 | 0.3 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 2.1 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 2.2 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 5.0 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 3.2 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.9 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.0 | 2.5 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 1.1 | GO:0006909 | phagocytosis(GO:0006909) |
0.0 | 1.3 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.0 | 0.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.2 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.0 | 1.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 4.1 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.0 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 2.8 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 1.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 1.2 | GO:0060996 | dendritic spine development(GO:0060996) |
0.0 | 0.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 5.4 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 2.0 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.3 | GO:0048839 | inner ear development(GO:0048839) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.5 | GO:0072563 | endothelial microparticle(GO:0072563) |
4.6 | 13.9 | GO:0097447 | dendritic tree(GO:0097447) |
3.3 | 9.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
3.0 | 9.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
2.7 | 8.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
2.6 | 10.6 | GO:0043259 | laminin-1 complex(GO:0005606) laminin-10 complex(GO:0043259) laminin-11 complex(GO:0043260) |
2.0 | 13.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.8 | 5.5 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
1.6 | 11.5 | GO:0071203 | WASH complex(GO:0071203) |
1.6 | 6.4 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
1.6 | 15.8 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
1.4 | 8.5 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
1.3 | 5.3 | GO:0097513 | myosin II filament(GO:0097513) |
1.3 | 6.5 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
1.3 | 10.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.2 | 5.0 | GO:0055087 | Ski complex(GO:0055087) |
1.2 | 4.8 | GO:0044094 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
1.2 | 9.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.1 | 5.3 | GO:0044308 | axonal spine(GO:0044308) |
1.1 | 19.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.1 | 8.5 | GO:0031931 | TORC1 complex(GO:0031931) |
1.1 | 6.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.0 | 5.1 | GO:0031905 | early endosome lumen(GO:0031905) |
1.0 | 6.0 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.9 | 6.4 | GO:0016589 | NURF complex(GO:0016589) |
0.9 | 10.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.9 | 4.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.9 | 6.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.8 | 3.9 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.8 | 7.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.8 | 2.3 | GO:0043291 | RAVE complex(GO:0043291) |
0.7 | 11.2 | GO:0090543 | Flemming body(GO:0090543) |
0.7 | 5.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.7 | 0.7 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.6 | 3.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.6 | 14.4 | GO:0046930 | pore complex(GO:0046930) |
0.6 | 17.8 | GO:0005685 | U1 snRNP(GO:0005685) |
0.5 | 8.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.5 | 15.0 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.5 | 3.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.5 | 4.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.5 | 3.0 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
0.5 | 3.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.5 | 2.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.5 | 2.8 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.4 | 1.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 6.9 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.4 | 5.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 1.7 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.4 | 3.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.4 | 5.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.4 | 13.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.4 | 26.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.4 | 5.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 1.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.3 | 2.2 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.3 | 1.9 | GO:0001740 | Barr body(GO:0001740) |
0.3 | 3.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 25.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 2.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.3 | 8.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 27.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.3 | 5.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 17.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 4.1 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.3 | 9.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.3 | 2.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 3.7 | GO:0001741 | XY body(GO:0001741) |
0.2 | 2.5 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 5.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 3.0 | GO:0097433 | dense body(GO:0097433) |
0.2 | 4.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 13.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 2.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 12.5 | GO:0002102 | podosome(GO:0002102) |
0.2 | 3.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 6.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 1.7 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.9 | GO:0045160 | myosin I complex(GO:0045160) |
0.2 | 3.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 1.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 3.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 4.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 0.6 | GO:0034455 | t-UTP complex(GO:0034455) |
0.2 | 1.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 1.7 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 2.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 4.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 3.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 4.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 3.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 4.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 3.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 7.9 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 14.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 2.3 | GO:0032059 | bleb(GO:0032059) |
0.1 | 1.1 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 7.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 8.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 4.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 1.0 | GO:0097413 | Cul2-RING ubiquitin ligase complex(GO:0031462) Lewy body(GO:0097413) |
0.1 | 2.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 1.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 3.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 2.1 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 3.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 2.4 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 2.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 6.5 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 2.1 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.2 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.1 | 7.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 3.0 | GO:0030496 | midbody(GO:0030496) |
0.1 | 2.8 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.8 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 3.0 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.2 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 6.1 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 3.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 20.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 3.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 1.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 3.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 8.9 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 6.9 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.1 | 2.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 1.2 | GO:0030133 | transport vesicle(GO:0030133) |
0.1 | 5.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 4.1 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 3.1 | GO:0044438 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.0 | 3.2 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 2.3 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 1.0 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 1.7 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 2.9 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 18.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 5.6 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 5.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 6.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 1.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 1.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 67.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 2.4 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 1.1 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 1.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.4 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
4.1 | 12.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
3.8 | 11.4 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
3.6 | 17.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
3.1 | 9.2 | GO:0032427 | GBD domain binding(GO:0032427) |
2.9 | 11.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
2.8 | 8.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
2.7 | 16.4 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
2.2 | 8.8 | GO:0005046 | KDEL sequence binding(GO:0005046) |
2.0 | 9.9 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
1.9 | 5.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.9 | 9.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
1.8 | 7.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
1.7 | 10.3 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
1.6 | 6.4 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
1.6 | 14.4 | GO:0015288 | porin activity(GO:0015288) |
1.6 | 6.2 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
1.5 | 8.9 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.5 | 4.4 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
1.4 | 8.7 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
1.4 | 8.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.3 | 6.6 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
1.3 | 5.1 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
1.2 | 8.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
1.1 | 5.6 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
1.1 | 7.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
1.1 | 10.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
1.0 | 10.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
1.0 | 3.9 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
1.0 | 2.9 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.9 | 12.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.9 | 4.4 | GO:0070404 | NADH binding(GO:0070404) |
0.8 | 5.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.8 | 3.9 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.8 | 2.3 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) azole transmembrane transporter activity(GO:1901474) |
0.8 | 2.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.7 | 8.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.7 | 16.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.6 | 3.2 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.6 | 49.3 | GO:0019003 | GDP binding(GO:0019003) |
0.6 | 3.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.6 | 15.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.6 | 6.7 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.6 | 14.2 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.6 | 4.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.6 | 1.7 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.6 | 8.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.5 | 20.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.5 | 1.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.5 | 3.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.5 | 6.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 3.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.4 | 2.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.4 | 5.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.4 | 4.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 2.4 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.4 | 7.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 2.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.4 | 17.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.4 | 16.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.4 | 3.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.4 | 5.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.4 | 5.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 7.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 3.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.4 | 6.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 1.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 21.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.3 | 12.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 11.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 3.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 1.0 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.3 | 2.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.3 | 8.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 3.7 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.3 | 3.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 2.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 4.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 6.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.3 | 9.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 2.9 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.3 | 1.1 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.3 | 5.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 8.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 11.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 3.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 3.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 8.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.3 | 3.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 5.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.3 | 7.2 | GO:0071949 | FAD binding(GO:0071949) |
0.3 | 4.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 3.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 3.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 5.7 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 3.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 2.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 6.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 12.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.2 | 3.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 2.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 0.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 13.8 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.2 | 4.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 0.6 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.2 | 1.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 2.8 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 2.4 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 0.9 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 3.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 3.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 9.1 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 2.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 4.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 3.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.9 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.3 | GO:0050072 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) m7G(5')pppN diphosphatase activity(GO:0050072) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.1 | 0.9 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 2.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.9 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.1 | 0.7 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.1 | 2.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.9 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 9.6 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 2.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 10.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 3.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 10.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 2.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 1.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 1.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 2.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 1.6 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 3.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 1.7 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 1.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 6.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 1.3 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 34.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 29.9 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 1.4 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.1 | 10.4 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 1.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 8.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 3.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 18.5 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 1.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 4.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 1.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.0 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 7.9 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 1.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 1.8 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 1.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 1.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 4.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 3.2 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 1.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 1.1 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.0 | 0.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 3.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 5.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.9 | GO:0022832 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
0.0 | 1.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 1.2 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 3.8 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.5 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 12.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 12.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 20.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 10.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 23.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.4 | 7.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 3.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 15.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 11.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 4.2 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 12.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 5.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 7.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 9.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 17.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 15.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 8.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 5.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 19.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 2.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 23.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 14.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 1.3 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 6.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 3.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 8.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 3.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 3.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 2.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 2.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 3.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 3.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 3.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 4.2 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 3.2 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 10.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 2.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 4.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 2.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 19.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.6 | 11.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.6 | 9.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.6 | 13.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.5 | 11.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 7.2 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.5 | 7.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.5 | 12.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 13.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 11.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 18.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.4 | 8.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.4 | 10.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 10.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 7.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 5.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 6.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 8.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 9.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 8.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 6.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 7.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 1.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 5.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 7.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 2.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 5.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 24.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.2 | 1.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 15.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 3.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 4.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 4.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 4.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 2.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 8.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 3.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 8.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 2.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 9.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 4.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 3.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 13.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 2.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 2.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 2.3 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 2.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 3.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 5.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 3.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 4.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 11.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 4.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 1.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 8.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 4.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 5.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 1.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 1.2 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 1.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 1.6 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.3 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 1.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |